Synektik

Synektik PEG

The PEG Ratio (Price/Earnings-to-Growth) of Synektik (SNT.WA) as of Oct 31, 2026 is 0.22. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.26 — a change of -17.18% (lower).

PEG

0.22

YoY

-17.18%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Synektik is 2025 0.22 . PEG Ratio (Price/Earnings-to-Growth) of Synektik was 2024 0.26 . It decreases by -17.18% lower compared to the previous year.

The Synektik PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
2.14 PLN
Jan 1, 2019
2.41 PLN
Jan 1, 2020
2.50 PLN
Jan 1, 2021
2.63 PLN
Jan 1, 2022
2.14 PLN
Jan 1, 2023
0.42 PLN
Jan 1, 2024
0.26 PLN
Jan 1, 2025
0.22 PLN
The Synektik PEG history
YEARPEGYoY
0.22-17.18%
0.26-38.03%
0.42-80.36%
2.14-18.61%
2.63+5.09%
2.50+3.70%
2.41+12.67%
2.14-60.31%
5.40-90.50%
56.82+828.86%
6.12—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

PEG Ratio (Price/Earnings-to-Growth) of Synektik is 0.22 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Synektik changed from 0.26 to 0.22, representing a -17.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Synektik since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Synektik

All Key Metrics — Synektik